FDA OKs Xofluza, First New Flu Antiviral in Nearly 20 Years FDA OKs Xofluza, First New Flu Antiviral in Nearly 20 Years

Baloxavir marboxil is for the treatment of acute uncomplicated influenza in people age 12 years and older who have been symptomatic for no more than 48 hours.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news